arabinofuranosyluracil has been researched along with Leukocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, H; Imaoka, T; Kawaguchi, T; Miyauchi, S; Motoyama, M; Odomi, M; Okada, T | 1 |
| Cleary, SM; Howell, SB; Kirmani, S; Mowry, J; Zimm, S | 1 |
2 other study(ies) available for arabinofuranosyluracil and Leukocytopenia
| Article | Year |
|---|---|
Leukopenia-inducing effect of a combination of a new 5-fluorouracil (5-FU)-derived drug, BOF-A2 (emitefur), with other 5-FU-derived drugs or BV-araU (sorivudine) in rats.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Arabinofuranosyluracil; Dose-Response Relationship, Drug; Drug Combinations; Fluorouracil; Leukopenia; Male; Rats; Rats, Sprague-Dawley | 1996 |
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
Topics: Adult; Aged; Arabinofuranosyluracil; Ascitic Fluid; Colonic Neoplasms; Cytarabine; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Leukopenia; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Peritonitis; Thrombocytopenia; Time Factors | 1990 |